CompanyTrack
E

ERGOMED CLINICAL RESEARCH LIMITED

Active Guildford

Other professional, scientific and technical activities n.e.c.

0 employees
Other professional, scientific and technical activities n.e.c.
E

ERGOMED CLINICAL RESEARCH LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 5 Apr 2004 Active Guildford, England 0 employees
Other professional, scientific and technical activities n.e.c.
Accounts Submitted 3 Oct 2025
Confirmation Statement Submitted 5 Mar 2025
Net assets £204.35K £96.80K 2023 year on year
Total assets £4.39M £2.12M 2023 year on year
Total Liabilities £4.19M £2.02M 2023 year on year
Charges 1
1 outstanding

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

1 Occam Court Surrey Research Park Guildford GU2 7HJ England

Credit Report

Discover ERGOMED CLINICAL RESEARCH LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£780.58k

Increased by £241.50k (+45%)

Net Assets

£204.35k

Increased by £96.80k (+90%)

Total Liabilities

£4.19M

Increased by £2.02M (+93%)

Turnover

£8.26M

Increased by £3.12M (+61%)

Employees

N/A

Debt Ratio

95%

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 25,650 Shares £26k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Sept 202525,650£26k£26k

Officers

Officers

4 active 13 resigned
Status
Gordana Tonkovic ReljanovicDirectorCroatianCroatia548 Feb 2021Active
Joanne BletcherSecretaryUnknownUnknown18 Sept 2019Active
Miroslav ReljanovicDirectorCroatianCroatia676 Apr 2004Active
Sybrand Gerhardus PretoriusDirectorAmericanUnited States5521 Aug 2024Active

Shareholders

Shareholders (1)

Ergomed Group Limited
100.0%
15 Mar 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Ergomed Group Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

ERGOMED GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN ACQUISITIONCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN HOLDCO 3 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN HOLDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN HOLDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EDEN TOPCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
EIGHTPLATFORM V LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ERGOMED CLINICAL RESEARCH LIMITED Current Company

Charges

Charges

1 outstanding

Documents

Company Filings

DateCategoryDescriptionDocument
29 Oct 2025CapitalAllotment of shares (GBP 25,651) on 2025-09-25View(3 pages)
3 Oct 2025AccountsAnnual accounts made up to 2024-12-31View(24 pages)
12 Aug 2025OfficersTermination of Jonathan Andrew Curtain as director on 2025-07-31View(1 page)
5 Mar 2025Confirmation StatementConfirmation statement made on 2025-02-19 with updatesView(4 pages)
5 Oct 2024AccountsAnnual accounts made up to 2023-12-31View(22 pages)
29 Oct 2025 Capital

Allotment of shares (GBP 25,651) on 2025-09-25

3 Oct 2025 Accounts

Annual accounts made up to 2024-12-31

12 Aug 2025 Officers

Termination of Jonathan Andrew Curtain as director on 2025-07-31

5 Mar 2025 Confirmation Statement

Confirmation statement made on 2025-02-19 with updates

5 Oct 2024 Accounts

Annual accounts made up to 2023-12-31

Recent Activity

Latest Activity

Allotment of shares (GBP 25,651) on 2025-09-25

3 months ago on 29 Oct 2025

Annual accounts made up to 2024-12-31

4 months ago on 3 Oct 2025

Termination of Jonathan Andrew Curtain as director on 2025-07-31

6 months ago on 12 Aug 2025

Confirmation statement made on 2025-02-19 with updates

11 months ago on 5 Mar 2025

Annual accounts made up to 2023-12-31

1 years ago on 5 Oct 2024